Advertisement

Anaphylaxis: Early Recognition and Management

  • Won Young Kim
Chapter

Abstract

Anaphylaxis is a serious systemic allergic reaction with a sudden onset after exposure to an offending agent [1]. Signs and symptoms can range from relatively mild to life threatening. About 2% of the population suffers from anaphylaxis during their lifetime; common causes are food, medications, and insect stings [2]. Recently the incidence of anaphylaxis is increasing in many countries; the prevention and treatment of anaphylaxis is an important clinical emergency which all healthcare professionals should be able to recognize and manage. Despite the release of a number of guidelines and updated practice on the management of anaphylaxis, there are identified gaps in knowledge and practice as well as barriers to care in emergency department (ED) [3]. Many of the gaps in the treatment of anaphylaxis included the lack of a practical definition of anaphylaxis as it related to physician.

References

  1. 1.
    Simons FE, Ardusso LR, Bilo MB, El-Gamal YM, Ledford DK, Ring J, et al. World Allergy Organization anaphylaxis guidelines: summary. J Allergy Clin Immunol. 2011a;127(3):587-93.e1-22.  https://doi.org/10.1016/j.jaci.2011.01.038.CrossRefPubMedGoogle Scholar
  2. 2.
    Yu JE, Lin RY. The epidemiology of anaphylaxis. Clin Rev Allergy Immunol. 2015;  https://doi.org/10.1007/s12016-015-8503-x.
  3. 3.
    Russell WS, Farrar JR, Nowak R, Hays DP, Schmitz N, Wood J, et al. Evaluating the management of anaphylaxis in US emergency departments: guidelines vs. practice. World J Emerg Med. 2013;4(2):98–106.  https://doi.org/10.5847/wjem.j.1920-8642.2013.02.003.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, et al. Second symposium on the definition and management of anaphylaxis: summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006a;117(2):391–7.  https://doi.org/10.1016/j.jaci.2005.12.1303.CrossRefPubMedGoogle Scholar
  5. 5.
    Muraro A, Roberts G, Worm M, Bilo MB, Brockow K, Fernandez Rivas M, et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy. 2014;69(8):1026–45.  https://doi.org/10.1111/all.12437.CrossRefPubMedGoogle Scholar
  6. 6.
    Muraro A, Roberts G, Clark A, Eigenmann PA, Halken S, Lack G, et al. The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology. Allergy. 2007;62(8):857–71.  https://doi.org/10.1111/j.1398-9995.2007.01421.x.CrossRefPubMedGoogle Scholar
  7. 7.
    Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, et al. Second symposium on the definition and management of anaphylaxis: summary report—second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. Ann Emerg Med. 2006b;47(4):373–80.  https://doi.org/10.1016/j.annemergmed.2006.01.018.CrossRefPubMedGoogle Scholar
  8. 8.
    Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, et al. Revised nomenclature for allergy for global use: report of the nomenclature review committee of the World Allergy Organization, october 2003. J Allergy Clin Immunol. 2004;113(5):832–6.  https://doi.org/10.1016/j.jaci.2003.12.591.CrossRefPubMedGoogle Scholar
  9. 9.
    Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy. 2000;30(8):1144–50.CrossRefGoogle Scholar
  10. 10.
    Ko BS, Kim JY, Seo DW, Kim WY, Lee JH, Sheikh A, et al. Should adrenaline be used in patients with hemodynamically stable anaphylaxis? Incident case control study nested within a retrospective cohort study. Sci Rep. 2016;6:20168.  https://doi.org/10.1038/srep20168.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Sala-Cunill A, Cardona V, Labrador-Horrillo M, Luengo O, Esteso O, Garriga T, et al. Usefulness and limitations of sequential serum tryptase for the diagnosis of anaphylaxis in 102 patients. Int Arch Allergy Immunol. 2013;160(2):192–9.  https://doi.org/10.1159/000339749.CrossRefPubMedGoogle Scholar
  12. 12.
    Caughey GH. Tryptase genetics and anaphylaxis. J Allergy Clin Immunol. 2006;117(6):1411–4.  https://doi.org/10.1016/j.jaci.2006.02.026.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Sampson HA, Munoz-Furlong A, Bock SA, Schmitt C, Bass R, Chowdhury BA, et al. Symposium on the definition and management of anaphylaxis: summary report. J Allergy Clin Immunol. 2005;115(3):584–91.  https://doi.org/10.1016/j.jaci.2005.01.009.CrossRefPubMedGoogle Scholar
  14. 14.
    Boyce JA, Assa'ad A, Burks AW, Jones SM, Sampson HA, Wood RA, et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol. 2010a;126(6 Suppl):S1–58.  https://doi.org/10.1016/j.jaci.2010.10.007.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Kemp SF, Lockey RF, Simons FE. Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy Organization. Allergy. 2008;63(8):1061–70.  https://doi.org/10.1111/j.1398-9995.2008.01733.x.CrossRefPubMedGoogle Scholar
  16. 16.
    Nowak R, Farrar JR, Brenner BE, Lewis L, Silverman RA, Emerman C, et al. Customizing anaphylaxis guidelines for emergency medicine. J Emerg Med. 2013;45(2):299–306.  https://doi.org/10.1016/j.jemermed.2013.01.018.CrossRefPubMedGoogle Scholar
  17. 17.
    Simons FE. Anaphylaxis. J Allergy Clin Immunol. 2010;125(2 Suppl 2):S161–81.  https://doi.org/10.1016/j.jaci.2009.12.981.CrossRefPubMedGoogle Scholar
  18. 18.
    Grabenhenrich L, Hompes S, Gough H, Rueff F, Scherer K, Pfohler C, et al. Implementation of anaphylaxis management guidelines: a register-based study. PLoS One. 2012;7(5):e35778.  https://doi.org/10.1371/journal.pone.0035778.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Simons KJ, Simons FE. Epinephrine and its use in anaphylaxis: current issues. Curr Opin Allergy Clin Immunol. 2010;10(4):354–61.  https://doi.org/10.1097/ACI.0b013e32833bc670.CrossRefPubMedGoogle Scholar
  20. 20.
    Simons FE, Ardusso LR, Bilo MB, El-Gamal YM, Ledford DK, Ring J, et al. World allergy organization guidelines for the assessment and management of anaphylaxis. World Allerg Organ J. 2011b;4(2):13–37.  https://doi.org/10.1097/WOX.0b013e318211496c.CrossRefGoogle Scholar
  21. 21.
    Smith PL, Kagey-Sobotka A, Bleecker ER, Traystman R, Kaplan AP, Gralnick H, et al. Physiologic manifestations of human anaphylaxis. J Clin Investig. 1980;66(5):1072–80.  https://doi.org/10.1172/jci109936.CrossRefPubMedGoogle Scholar
  22. 22.
    Lieberman P, Nicklas RA, Oppenheimer J, Kemp SF, Lang DM, Bernstein DI, et al. The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol. 2010;126(3):477-80.e1-42.  https://doi.org/10.1016/j.jaci.2010.06.022.CrossRefPubMedGoogle Scholar
  23. 23.
    Soar J, Pumphrey R, Cant A, Clarke S, Corbett A, Dawson P, et al. Emergency treatment of anaphylactic reactions—guidelines for healthcare providers. Resuscitation. 2008;77(2):157–69.  https://doi.org/10.1016/j.resuscitation.2008.02.001.CrossRefPubMedGoogle Scholar
  24. 24.
    Kanwar M, Irvin CB, Frank JJ, Weber K, Rosman H. Confusion about epinephrine dosing leading to iatrogenic overdose: a life-threatening problem with a potential solution. Ann Emerg Med. 2010;55(4):341–4.  https://doi.org/10.1016/j.annemergmed.2009.11.008.CrossRefPubMedGoogle Scholar
  25. 25.
    Brown SG, Mullins RJ, Gold MS. Anaphylaxis: diagnosis and management. Med J Aust. 2006;185(5):283–9.PubMedGoogle Scholar
  26. 26.
    Sheikh A, Ten Broek V, Brown SG, Simons FE. H1-antihistamines for the treatment of anaphylaxis: Cochrane systematic review. Allergy. 2007;62(8):830–7.  https://doi.org/10.1111/j.1398-9995.2007.01435.x.CrossRefPubMedGoogle Scholar
  27. 27.
    Boyce JA, Assa'ad A, Burks AW, Jones SM, Sampson HA, Wood RA, et al. Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-sponsored expert panel report. J Allergy Clin Immunol. 2010b;126(6):1105–18.  https://doi.org/10.1016/j.jaci.2010.10.008.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Foti C, Cassano N, Panebianco R, Calogiuri GF, Vena GA. Hypersensitivity reaction to ranitidine: description of a case and review of the literature. Immunopharmacol Immunotoxicol. 2009;31(3):414–6.  https://doi.org/10.1080/08923970902739078.CrossRefPubMedGoogle Scholar
  29. 29.
    Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev. 2001;(1):Cd002178.  https://doi.org/10.1002/14651858.cd002178.
  30. 30.
    Choo KJ, Simons E, Sheikh A. Glucocorticoids for the treatment of anaphylaxis: cochrane systematic review. Allergy. 2010;65(10):1205–11.  https://doi.org/10.1111/j.1398-9995.2010.02424.x.CrossRefPubMedGoogle Scholar
  31. 31.
    Thomas M, Crawford I. Best evidence topic report. Glucagon infusion in refractory anaphylactic shock in patients on beta-blockers. Emerg Med J. 2005;22(4):272–3.  https://doi.org/10.1136/emj.2005.023507.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Lee S, Bellolio MF, Hess EP, Erwin P, Murad MH, Campbell RL. Time of onset and predictors of biphasic anaphylactic reactions: a systematic review and meta-analysis. J Allergy Clin Immunol Pract. 2015;3(3):408-16.e1-2.  https://doi.org/10.1016/j.jaip.2014.12.010.CrossRefPubMedGoogle Scholar
  33. 33.
    Ko BS, Kim WY, Ryoo SM, Ahn S, Sohn CH, Seo DW, et al. Biphasic reactions in patients with anaphylaxis treated with corticosteroids. Ann Allergy Asthma Immunol. 2015;115(4):312–6.  https://doi.org/10.1016/j.anai.2015.07.015.CrossRefPubMedGoogle Scholar
  34. 34.
    Alqurashi W, Stiell I, Chan K, Neto G, Alsadoon A, Wells G. Epidemiology and clinical predictors of biphasic reactions in children with anaphylaxis. Ann Allergy Asthma Immunol. 2015;115(3):217-23.e2.  https://doi.org/10.1016/j.anai.2015.05.013.CrossRefGoogle Scholar
  35. 35.
    Lieberman P. Biphasic anaphylactic reactions. Ann Allergy Asthma Immunol. 2005;95(3):217–26; quiz 26, 58.  https://doi.org/10.1016/s1081-1206(10)61217-3.CrossRefPubMedGoogle Scholar
  36. 36.
    Rohacek M, Edenhofer H, Bircher A, Bingisser R. Biphasic anaphylactic reactions: occurrence and mortality. Allergy. 2014;69(6):791–7.  https://doi.org/10.1111/all.12404.CrossRefPubMedGoogle Scholar
  37. 37.
    Grunau BE, Wiens MO, Rowe BH, McKay R, Li J, Yi TW, et al. Emergency department corticosteroid use for allergy or anaphylaxis is not associated with decreased relapses. Ann Emerg Med. 2015;66(4):381–9.  https://doi.org/10.1016/j.annemergmed.2015.03.003.CrossRefPubMedGoogle Scholar
  38. 38.
    Smit DV, Cameron PA, Rainer TH. Anaphylaxis presentations to an emergency department in Hong Kong: incidence and predictors of biphasic reactions. J Emerg Med. 2005;28(4):381–8.  https://doi.org/10.1016/j.jemermed.2004.11.028.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  • Won Young Kim
    • 1
  1. 1.Department of Emergency MedicineUniversity of Ulsan College of Medicine, Asan Medical CenterSeoulSouth Korea

Personalised recommendations